Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $5.29 USD
Change Today +0.115 / 2.22%
Volume 1.6M
CYTR On Other Exchanges
As of 3:21 PM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

C. Ronald Kahn M.D., DSc

Member of Scientific Advisory Board of CytRx Laboratories Inc, CytRx Corporation
AgeTotal Calculated CompensationThis person is connected to 102 board members in 7 different organizations across 14 different industries.

See Board Relationships


Dr. C. Ronald Kahn, MD, DSc serves as the President and Chief Executive Officer of Joslin Clinic. Dr. Kahn serves as Scientific Advisor of Cohbar, Inc. He serves as the Senior Investigator and Head of the Joslin Section on Obesity. He serves as the Chief Academic Officer and Head of The Section On Integrative Physiology at the Joslin Diabetes Center, Inc. Dr. Kahn is the preeminent investigator of insulin signal transduction and mechanisms of altered signaling in disease. ...

Read Full Background

Corporate Headquarters*

11726 San Vicente Boulevard
Los Angeles, California 90049

United States

Phone: 310-826-5648
Fax: 310-826-6139

Board Members Memberships*

Chief Academic Officer


MS 1984
University of Louisville
BS 1964
University of Louisville
MD 1968
University of Louisville
Honorary Doctorate
Université de la Sorbonne - Université de Paris
Honorary Doctorate
Københavns Universitet

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTR:US $5.29 USD +0.115


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTRX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at